menu
Your Cart

ITA4620

ITA4620-1
ITA4620-2
ITA4620-1
ITA4620-2
ITA4620
  • Catalog: ITA4620
  • Gene/Protein: ADAMTS18
  • Product Description: Immunotag™ ADAMTS18 Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ ADAMTS18 Antibody
Antibody Specification
Datasheet

Target Protein ADAMTS18
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IF/ICC,ELISA
Recommended Dilution WB 1:500~1:1000, IF/ICC 1:100-1:500
Concentration 1 mg/ml
Reactive Species Human,Mouse
Host Species Rabbit
Immunogen A synthesized peptide
Specificity ADAMTS18 Antibody detects endogenous levels of total ADAMTS18
Purification The antiserum was purified by peptide affinity chromatography.
Form Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt
Gene Name ADAMTS18
Accession No. Q8TE60
Alternate Names A disintegrin and metalloproteinase with thrombospondin motifs 18; A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 18; A disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 21; ADAM metallopeptidase with thrombospondin type 1 motif 18; ADAM-TS 18; ADAM-TS18; ADAMTS 18; ADAMTS-18; ADAMTS18; ADAMTS21; ATS18_HUMAN; Disintegrin and metalloprotease like protein; EC 3.4.24.; KNO2;
Description Variant Leu-179 has been originally reported as disease-causing mutation in a patient with Knobloch syndrome (PubMed:21862674). It has been subsequently shown that Knobloch syndrome in the patient was due to an intronic mutation in COL18A1. Variant Leu-179 is, therefore, not responsible for the disease phenotype (PubMed:23667181).
Cell Pathway/ Category Primary Polyclonal Antibody
Protein MW 135 KD
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US